ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 30 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 3,053 | +2.9% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 2,968 | +0.5% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 2,952 | +107.4% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 1,423 | +13.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 1,256 | +2.5% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 1,225 | -0.1% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 1,226 | +7.5% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 1,140 | +5.1% | 0.00% | – |
Q2 2020 | $2,000 | -33.3% | 1,085 | -65.9% | 0.00% | – |
Q1 2020 | $3,000 | -62.5% | 3,185 | +2.7% | 0.00% | – |
Q4 2019 | $8,000 | -83.3% | 3,100 | -74.6% | 0.00% | – |
Q3 2019 | $48,000 | 0.0% | 12,189 | +3.7% | 0.00% | – |
Q2 2019 | $48,000 | -68.0% | 11,751 | -44.9% | 0.00% | – |
Q1 2019 | $150,000 | +97.4% | 21,311 | +51.9% | 0.00% | – |
Q4 2018 | $76,000 | +5.6% | 14,028 | +110.3% | 0.00% | – |
Q3 2018 | $72,000 | +63.6% | 6,669 | +95.1% | 0.00% | – |
Q2 2018 | $44,000 | -57.3% | 3,419 | -63.4% | 0.00% | – |
Q1 2018 | $103,000 | +281.5% | 9,336 | +246.4% | 0.00% | – |
Q4 2017 | $27,000 | – | 2,695 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |